Objectives: To study the prevalence of Acinetobacter species infection, its antibiogram, and associated risk factors. Methods: Retrospective time-bound study for 6 months. The study includes 85 clinical isolates of Acinetobacter species isolated from various specimens. The identification and antibiotic susceptibility testing by Kirby Bauer Disk Diffusion method and Vitek Compact system 2. Results: Maximum isolation of Acinetobacter species was from Sputum (32.9%), BAL (21.1%), Urine (17.64%), Blood (11.7%), and others(16.47%).The species was most sensitive to colistin (97.64%) and polymyxin B (99.99%). The species was most resistant to Ciprofloxacin (96.4%) and Ceftriaxone (92.9%). The common risk factors include Immunosuppressed individuals, comorbid conditions, indiscriminate antibiotic usage, and prolonged ICU stays. Conclusion: Acinetobacter has emerged as a major hospital-acquired pathogen. Antibiotic resistance increased. The availability of an antibiogram against A. baumannii is important for effective treatment and minimizing the emergence of antibiotic resistance. So, Proper antibiotic stewardship is required to abbreviate antibiotic resistance.
Impact Factor
2022: 6.012
This work is licensed under a